ACTIVE

CoBioRes

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result
-28,8 k €
-198,5 %over 1 year
Gross margin
-28,4 k €
-176,7 %over 1 year
Equity
337,8 k €
-7,9 %over 1 year

Identity

Source · BCE/KBO

CoBioRes is a Public limited company incorporated in 2013. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Leuven.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0525.845.116
Incorporation
28/03/2013
Legal form
Public limited company
Registered office
Herestraat 49 box 913
3000 Leuven · FlandreSee on map
Contributed capital
8 000 000,00 €
Latest accounts
31/12/2025
Joint committees (1)
  • 207
Signals
Solid equityLow riskGood liquidity

Financials

Source · NBB, 12 filings

Trend over 12 financial years

20252024202320222021
Income statement
Gross margin-28,4 k €-10,2 k €-48,4 k €-57 k €1,3 M €
EBITDA-28,4 k €-10,2 k €-51,3 k €-62,6 k €664,2 k €
Operating result-28,4 k €-10,2 k €-51,3 k €-62,6 k €645,2 k €
Net result-28,8 k €-9,7 k €-52,9 k €-63,2 k €733,7 k €
Balance sheet
Equity337,8 k €366,6 k €376,3 k €429,2 k €492,4 k €
Total assets338 k €366,6 k €380,6 k €429,2 k €549,6 k €
Cash248,8 k €165,2 k €112,8 k €92,9 k €193,3 k €
Debts247 €–4,4 k €–57,3 k €
Other
Workforce––––5,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 8 ended

Active mandates

Desire COLLEN

Chairman of the board of directors · since 30 juin 2022 · until 30 juin 2028

Active
SOFIA

Director · since 30 juin 2022 · until 30 juin 2028 · 0465.580.402

Represented by Chris BUYSE

Active

Ended mandates

Patcobel UK Ltd.

Chairman of the board of directors · since 01 janvier 2020 · until 26 mai 2022

Represented by Désiré COLLEN

Ended
Life Sciences Research Partners

Director · since 09 décembre 2016 · until 26 mai 2022 · 0435.768.243

Represented by Nele KINDT

Ended
PATCOBEL

Chairman of the board of directors · since 09 décembre 2016 · until 31 décembre 2019 · 0874.895.359

Represented by Collen Désiré

Ended
PATCOBEL

Managing director · since 09 décembre 2016 · until 26 mai 2022 · 0874.895.359

Represented by Désiré COLLEN

Ended

Other companies at this address

Herestraat 49 3000 Leuven
CompanyCBE no.
ALFAGEN: Alumni van de FAculteit GENeeskunde KU Leuven● Active
0410.876.855
APOTHEEK DE HALLEN● Active
0823.041.535
Association internationale pour l'Etude de l'Ostéosynthèse, Section belge - Internationale Vereniging voor de Studie der Osteosyntese, Afdeling België● Active
0416.464.352
Belgian Association for Neuro-Oncology● Active
0875.672.448
BELGIAN ASSOCIATION FOR PAEDIATRIC ANAESTHESIOLOGY● Active
0500.683.811
BELGIAN ASSOCIATION FOR REGIONAL ANESTHESIA● Active
0476.083.423
Belgian College of Neuropsychopharmacology and Biological Psychiatry● Active
0415.048.548
Belgian Environmental Mutagen Society● Active
0423.884.357
Belgian Society for Occupational Hygiene● Active
0445.599.291
Belgian Society for Tissue Engineering● Active
0715.913.646
BELGIAN SOCIETY ON THROMBOSIS AND HAEMOSTASIS● Active
0450.076.733
Belgian Thyroid Club● Active
0758.644.918
BELGISCHE VERENIGING VOOR ASSISTENTEN NEUS, KEEL- EN OORZIEKTEN (VA-NKO)● Active
0700.911.508
Beroepsvereniging van de Geneesheren en Tandartsen van UZ Leuven● Active
0541.610.683
Centrum voor Ontwikkelingsstoornissen Leuven - Limburg● Active
0431.898.141
Centrum voor Rampengeneeskunde en Rampenmanagement● Active
0447.755.859
Diana vzw● Active
0644.654.377
Eros● Active
0563.361.944
European Burns Association - Europese Brandwondenvereniging● Active
0461.516.003
European Conference on Infections in Leukemia● Active
0677.600.626

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date01/07/202620/07/202517/06/202429/07/202311/08/202223/06/2021
General meeting16/06/202617/06/202514/06/202430/06/202330/06/202218/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 12 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202516/06/202601/07/2026DutchPDF
Abridged model31/12/202417/06/202520/07/2025DutchPDF
Abridged model31/12/202314/06/202417/06/2024DutchPDF
Abridged model31/12/202230/06/202329/07/2023DutchPDF
Abridged model31/12/202130/06/202211/08/2022DutchPDF
Abridged model31/12/202018/06/202123/06/2021DutchPDF
Abridged model31/12/201928/05/202024/06/2020DutchPDF
Abridged model31/12/201831/05/201921/06/2019DutchPDF
Abridged model31/12/201731/05/201812/06/2018DutchPDF
Abridged model31/12/201625/05/201701/07/2017DutchPDF
Abridged model31/12/201526/05/201608/09/2016DutchPDF
Abridged model31/12/201428/05/201520/07/2015DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 8 ended

Active mandates

Desire COLLEN

Chairman of the board of directors · since 30 juin 2022 · until 30 juin 2028

Active
SOFIA

Director · since 30 juin 2022 · until 30 juin 2028 · 0465.580.402

Represented by Chris BUYSE

Active

Ended mandates

Patcobel UK Ltd.

Chairman of the board of directors · since 01 janvier 2020 · until 26 mai 2022

Represented by Désiré COLLEN

Ended
Life Sciences Research Partners

Director · since 09 décembre 2016 · until 26 mai 2022 · 0435.768.243

Represented by Nele KINDT

Ended
PATCOBEL

Chairman of the board of directors · since 09 décembre 2016 · until 31 décembre 2019 · 0874.895.359

Represented by Collen Désiré

Ended
PATCOBEL

Managing director · since 09 décembre 2016 · until 26 mai 2022 · 0874.895.359

Represented by Désiré COLLEN

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates27/11/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates10/02/2020
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares16/10/2017
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Capital / shares04/01/2017
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Capital / shares11/12/2014
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Other18/04/2013
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-28,8 k €↓
  2. 2024
    Annual accounts 2024-9,7 k €↑
  3. 2023
    Annual accounts 2023-52,9 k €↑
  4. 2022
    Annual accounts 2022-63,2 k €↓
  5. 2021
    Annual accounts 2021733,7 k €↑
  6. 2020
    Annual accounts 2020-2,3 M €↓
  7. 2019
    Annual accounts 2019-2,2 M €↓
  8. 2018
    Annual accounts 2018-916 k €↓
  9. 2017
    Annual accounts 2017-731,9 k €↑
  10. 2016
    Annual accounts 2016-829,2 k €↓
  11. 2015
    Annual accounts 2015-451 k €↑
  12. 2014
    Annual accounts 2014-833,9 k €
  13. 28/03/2013
    IncorporationPublic limited company